EBOS Group Limited/Announcement
EBOS Group Limited logo

Senior Manager Details

Insider Disclosure31 May 2022EBOHealthcare

EBOS Group Limited. NZBN 9429031998840
Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia.

Phone: +61 3 9918 5555, Fax: +61 3 9918 5588.

www.ebosgroup.com




1 June 2022

NZX/ASX Code: EBO


Senior Manager Details



In accordance with NZX Listing Rule 3.20.1(a), EBOS Group Limited advises that Mr Matthew Muscio

is a Senior Manger as defined in the NZX Listing Rules.



Authorised for lodgement with NZX and ASX by:

Janelle Cain

General Counsel

EBOS Group Limited

+ 61 3 9918 5555

---

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

EBOS Group Limited

Date this disclosure made:

1-Jun-22

Date on which issuer listed or appointment made:

31-May-22

Director or senior manager giving disclosure

Full name:

Matthew Muscio

Name of listed issuer:

EBOS Group Limited

Name of related body corporate (if applicable):

Position held in listed issuer:

Chief Executive Officer - Devices

Summary of relevant interest (excluding specified derivatives)

Class of quoted financial product:

Ordinary shares

Number held in class:

143,692

Nature of relevant interest:

Indirect/ beneficial interest

Current registered holder:

White Room Nominees Pty Ltd atf

the Muscio Family Trust

Summary of specified derivatives relevant interest (if applicable)

Type of derivative:

Class of underlying financial products:

Details of derivative

The notional value of the derivative (if any) or the notional amount of underlying

products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price specified in the terms of the derivative(if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Certification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclosure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:1-Jun-22
Name and title of authorised person:

Janelle Cain, General Counsel,

EBOS Group Limited

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • MEL — Meridian Energy Limited: D&O Initial Disclosures
    2022-05-31

    Initial Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(1) and 298(1), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Meridian Energy Limited Date this disclosure made: 31/05/2022 Date on which issuer…”

  • OCA — Oceania Healthcare Limited: D&O Ongoing Disclosure Notices (multiple)
    2022-06-27

    Details of derivative - The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): N/A A statement as to whether the derivative is cash settled or physically settled: N/A Maturity date of the derivative (if any): N/…”

  • ERD — EROAD: Ongoing Disclosure Notice – Selwyn Pellett
    2022-06-08

    To NZX Limited; and Name of listed issuer:EROAD Limited Date this disclosure made:8-Jun-22 Date of last disclosure:6-Dec-21 Full name(s):Selwyn Lyle Pellett Name of listed issuer:EROAD Limited Name of related body corporate (if applicable):Not applicable Position held in listed i…”